I
|
Chlorpheniramine20,43
|
1 - Almukainzi et al., 2015 (10.1208/s12249-014-0241-5)
|
Hydrocodone28
|
2 - Alvarez et al., 2011 (10.1002/jps.22472)
|
Oseltamivir41,45
|
3 - Bajaj et al., 2012 (10.3109/03639045.2012.683440)
|
Paroxetine hydrochloride41
|
4 - Bialer, Midha, 2010 (10.1111/j.1528-1167.2010.02573.x)
|
Sildenafil citrate20,41,43,47
|
5 - Breda et al., 2009 (10.1016/j.ijpharm.2008.12.026)
|
II
|
Azithromycin20,41,43
|
6 - Campos et al., 2007 (10.1055/s-0031-1296624)
|
Bosentan25,54
|
7 - Charoo et al., 2014 (10.1002/jps.2418)
|
Carbamazepine4,20,33,39,47,50,52,54
|
8 - Chilukuri et al., 2014(10.1093/chromsci/bmt110)
|
Carvedilol41,43,47
|
9 - Cho et al., 2012 (10.1007/s40005-012-0020-9)
|
Celecoxib20,21
|
10 - Choonara et al., 2014 (10.1208/s12249-014-0271-z)
|
Clarithromycin35,41
|
11 - Chuasuwan et al., 2009 (10.1002/jps.21525)
|
Clozapine16,61
|
12 - Corrêa et al., 2014 (10.1080/10408347.2013.826573)
|
Darunavir ethanolate12
|
13 - Cristofoletti et al., 2016 (10.1016/j.xphs.2015.11.033)
|
Dasatinib55
|
14 - da Fonseca et al., 2009da Fonseca LB, Labastie M, Sousa VP, Volpato NM. Development and validation of a discriminative dissolution test for nimesulide suspensions. AAPS PharmSciTech. 2009;10(4):1145-52.(10.1208/s12249-009-9320-4)
|
Deferasirox18
|
15 - da Silva et al., 2015 (10.1208/s12249-015-0407-9)
|
Diclofenac potassium11
|
16 - Dias et al., 2014 (10.1007/s10973-014-4142-3)
|
Felbamate4,20
|
17 - Douroumis, Fahr, 2007 (10.1016/j.colsurfb.2007.05.009)
|
Fosamprenavir calcium8,54
|
18 - Durdunji et al.,2016 (10.1016/j.ejpb.2016.02.006)
|
Ibuprofen2,20,33,38,43,46,47,50,52,14
|
19 - Fairstein et al., 2013 (10.1208/s12248-013-9462-x)
|
Indomethacin20,40
|
20 - FDA, NICHD (bpca.nichd.nih.gov/collaborativeefforts/initiatives/documents/formulations_platform_report1.pdf)
|
Loperamide HCl56,59
|
21 - Fong et al., 2015 (10.1016/j.ijpharm.2015.10.029)
|
Megestrol acetate26,36
|
22 - Fujioka et al., 2007 (10.1016/j.jconrel.2007.03.002
|
Meloxicam8,9,41,43
|
23 - Fujioka et al., 2008 (10.1016/j.ijpharm.2007.10.008)
|
Methylphenidate HCl20
|
24 - Ghadi, Dand, 2017 (10.1016/j.jconrel.2017.01.014)
|
Mycophenolate mofetil20,47,49
|
25 - Ghasemian et al., 2016 (10.15171/apb.2016.029)
|
Nevirapine20,33,51
|
26 - Guk et al., 2017 (10.1111/bcpt.12677)
|
Nimesulide14
|
27 - Helmy, Bedaiwy, 2016 (10.14227/DT230316P32)
|
Phenytoin33,38,43,50,52
|
28 - Hemmingsen et. al., 2011 (10.3390/pharmaceutics3010073)
|
Posaconazole13,29
|
29 - Hens et al., 2016 (10.1002/jps.24690)
|
Rufinamide4
|
30 - Israr et al., 2014 (10.1590/S1984-82502014000400030)
|
Simvastatin20,41,47,50
|
31 - Jha et al., 2014 (10.1155/2014/452051)
|
III
|
Ampicillin49
|
32 - Kalvakuntla et al., 2016 (10.15171/apb.2016.013)
|
Cefadroxil20
|
33 - Kasim et al., 2004 (10.1021/mp034006h)
|
Cefprozil20
|
34 - Khan et al., 2010 (10.1208/s12249-010-9505-x)
|
Clavulanate potassium20,54
|
35 - Kristin et al., 2017 (10.1016/j.ejps.2017.02.003)
|
Codeine20,33,38,43,47
|
36 - Li et al., 2015 (10.1007/s12272-015-0604-9)
|
Esomeprazole magnesium20,54
|
37 - Liew et al., 2014 (10.3109/03639045.2013.798805
|
Pantoprazole sodium6,20,54
|
38 - Lindenberg et al., 2004 (10.1016/j.ejpb.2004.03.001)
|
Rosuvastatin20,54
|
39 - Mishra et al., 2010Mishra V, Gupta U, Jain N. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies. Pharmazie. 2010;65(3):155-61.(10.1691/ph.2010.9231)
|
IV
|
Acetazolamide20,24,33,38
|
40 - Nokhodchi et al., 2005 (sites.ualberta. ca/~csps/JPPS8(1)/ A.Nokhodchi/indomethacin.pdf)
|
Aprepitant24,32
|
41 - Ono et al., 2016 (10.5599/admet.4.4.338)
|
Azathioprine20,24,33,38,50
|
42 - Pál et al., 2013 (10.1016/j.ejps.2013.03.006)
|
Benzoyl metronidazole15,50
|
43 - Papich, Martinez, 2015 (10.1208/s12248-015-9743-7)
|
Cefdinir20,41,53,54
|
44 - Petrusevska et al., 2015 (10.1002/jps.24350)
|
Cefixime20,47
|
45 - Ploger et al., 2018 (10.1016/j.xphs.2018.01.025)
|
Two or more
|
Acyclovir: III20,33,38,39,50, IV20,41
|
|
Albendazole: II33,38,50,52,57, IV38
|
|
Allopurinol: I20,54, II41, III20,38,54, IV33,50
|
|
Amoxicillin: III33,43,52, IV47,50,52
|
|
Cefpodoxime proxetil: II34, IV3
|
46 - Potthast et al., 2005 (10.1002/jps.20444)
|
Cefuroxime axetil: II30, IV20,47,54
|
47 - Ramirez et al., 2010 (10.1111/j.1365-2125.2010.03757.x)
|
Cephalexin: III37,52, IV20,43,52
|
48 - Resende et al., 2016 (10.1590/s1984-82502016000400005)
|
Ciprofloxacin: II38, III20,33,50,52,IV5,38,43
|
49 - Rumondor et al., 2016 (10.1016/j.xphs.2015.11.004)
|
Doxycycline: I38,43, III52, IV33,43,50,52
|
50 - Santos et al., 2014 (10.1590/S1984-82502011000100002)
|
Famotidine: III20,41,31, IV24,47
|
51 - Sarkar et al., 2008 (10.4103/0250-474X.45401)
|
Fexofenadine HCl: I20,41 , III9,20
|
52 - Shawahna, 2016 (10.1208/s12248-016-9885-2)
|
Fluconazole: I20,38, II41, III20,27,33,47,50
|
53 - Thota et al., 2014 (IJPSN-3-20-14-KISHAN)
|
Griseofulvin: II20,22,23,33,38,39,54, IV20,33,54
|
54 - Tiwari et al., 2014 (10.7897/2277-4572.035187)
|
Levetiracetam: I43,44, III20,47
|
55 - Vaidhyanathan et al., 2019 (10.1016/j.xphs.2018.11.005)
|
Linezolid: I27,43, IV20,43,54
|
56 - Venkateswarlu et al., 2016 (10.15171/apb.2016.050)
|
Mercaptopurine: II58,60, IV20
|
57 - Vidal et al., 2014 (10.14227/DT210214P42)
|
Montelukast sodium: I20,41,54, II1
|
58 - Wang et al., 2015 (10.1016/j.bmcl.2015.01.022)
|
Nitrofurantoin: II38, IV33,52
|
59 - Widjojokusumo et al., 2013 (10.1007/s11814-013-0115-7)
|
Nystatin: III20,33,38, IV38,42
|
60 - Yang et al., 2016 (10.1248/cpb.c15-00949)
|
Oxcarbazepine: II4,17, IV20,47
|
61 - Zeng et al., 2013 (10.1208/s12249-013-9973-x)
|
Pseudoephedrine HCl: I41 , IV41
|
|
Pyrazinamide: I38,20, III33,20,47
|
|
Spironolactone: II33,38,48, IV38
|
|
Sulfamethoxazole: II10,20,38, IV20,33,50,52
|
|
Trimethoprim: II38, IV20,33,50,52
|
|